23andMe: Reza Afkhami

23andMe has named Reza Afkhami chief corporate development officer. In that role, he will oversee industry collaborations for the firm's therapeutics pipeline, research services, and consumer genomics operations. Afkhami joins 23andMe after serving as senior VP of corporate development and strategy at Global Blood Therapeutics while that firm was being acquired by Pfizer late last year.